{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:38Z","timestamp":1790916818014,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>This review examines the complex bidirectional relationship between cardiovascular disease and various dementia subtypes, including Alzheimer\u2019s disease, vascular dementia, Lewy body dementia, and frontotemporal dementia. Traditional cardiovascular risk factors such as hypertension, coronary artery disease, arrhythmia, and diabetes mellitus are strongly linked to the development of dementia. Emerging evidence indicates that cognitive decline can exacerbate cardiovascular risks through heightened inflammatory responses and compromised autonomic regulation. Additionally, this review explores trials that investigate the impact of cardiovascular medications, such as antihypertensive and statin therapies, on cognitive outcomes, as well as studies examining how dementia treatments like anticholinesterases affect cardiovascular health. This review emphasizes the importance of early identification of at-risk individuals, integrated care approaches, and lifestyle interventions aimed at reducing both cardiovascular disease and dementia risk, ultimately aiming to enhance patient outcomes and quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/crd.0000000000000730","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T09:02:54Z","timestamp":1716541374000},"page":"483-487","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Cardiovascular Disease and Dementia"],"prefix":"10.1097","volume":"34","author":[{"given":"Lillian","family":"Huang","sequence":"first","affiliation":[{"name":"From the Department of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Meir","sequence":"additional","affiliation":[{"name":"Department of Medicine, Long Island Jewish Hospital, Queens, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"e0271611","DOI":"10.1371\/journal.pone.0271611","article-title":"Risk factors for dementia in the context of cardiovascular disease: a protocol of an overview of reviews.","volume":"17","author":"Brain","year":"2022","journal-title":"PLoS One"},{"key":"R2-20261002","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/alz.12343","article-title":"Association of cardiovascular risk burden with risk of dementia and brain pathologies: a population-based cohort study.","volume":"17","author":"Song","year":"2021","journal-title":"Alzheimers Dement"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"9777","DOI":"10.3390\/ijms23179777","article-title":"Shared risk factors between dementia and atherosclerotic cardiovascular disease.","volume":"23","author":"Nordestgaard","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"1095236","DOI":"10.3389\/fepid.2023.1095236","article-title":"Cardiovascular disease, associated risk factors, and risk of dementia: an umbrella review of meta-analyses.","volume":"3","author":"Brain","year":"2023","journal-title":"Front Epidemiol"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"1257367","DOI":"10.3389\/fnagi.2023.1257367","article-title":"Cardiovascular disease risk models and dementia or cognitive decline: a systematic review.","volume":"15","author":"Jia","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"R6-20261002","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/jpm12040572","article-title":"Rhythm control better prevents dementia than rate control strategies in patients with atrial fibrillation-a nationwide cohort study.","volume":"12","author":"Lin","year":"2022","journal-title":"J Pers Med"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"108575","DOI":"10.1016\/j.pharmthera.2023.108575","article-title":"Hypertension & dementia: pathophysiology & potential utility of antihypertensives in reducing disease burden.","volume":"253","author":"Lyon","year":"2023","journal-title":"Pharmacol Ther"},{"key":"R8-20261002","doi-asserted-by":"crossref","first-page":"e2013","DOI":"10.1212\/WNL.0000000000200255","article-title":"Association of cardiovascular risk trajectory with cognitive decline and incident dementia.","volume":"98","author":"Farnsworth von Cederwald","year":"2022","journal-title":"Neurology"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fcvm.2020.00005","article-title":"Hypertension and the risk of dementia.","volume":"7","author":"Sierra","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"2617970","DOI":"10.1155\/2020\/2617970","article-title":"Alzheimer\u2019s disease and cardiovascular disease: a particular association.","volume":"2020","author":"Tini","year":"2020","journal-title":"Cardiol Res Pract"},{"key":"R11-20261002","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13195-023-01360-0","article-title":"Statins and cognitive decline in patients with Alzheimer\u2019s and mixed dementia: a longitudinal registry-based cohort study.","volume":"15","author":"Petek","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3233\/JAD-141089","article-title":"Cholinesterase inhibitors: cardioprotection in Alzheimer\u2019s disease.","volume":"42","author":"Monacelli","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/gerona\/glt141","article-title":"Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort.","volume":"69","author":"Dublin","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1161\/STROKEAHA.116.012658","article-title":"Blood pressure and risk of vascular dementia: evidence from a primary care registry and a cohort study of transient ischemic attack and stroke.","volume":"47","author":"Emdin","year":"2016","journal-title":"Stroke"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/2040622317712442","article-title":"Strategies for dementia prevention: latest evidence and implications.","volume":"8","author":"Rakesh","year":"2017","journal-title":"Ther Adv Chronic Dis"},{"key":"R16-20261002","first-page":"135","article-title":"Heart disease as a risk factor for dementia.","volume":"5","author":"Justin","year":"2013","journal-title":"Clin Epidemiol"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3233\/JAD-190485","article-title":"Cardiovascular disease, diabetes mellitus, and hypertension in Lewy body disease: a comparison with other dementia disorders.","volume":"71","author":"Javanshiri","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","article-title":"Dementia with Lewy bodies: an update and outlook.","volume":"14","author":"Outeiro","year":"2019","journal-title":"Mol Neurodegener"},{"key":"R19-20261002","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10286-023-00962-w","article-title":"Exploring the prevalence of undetected bradyarrhythmia in dementia with Lewy bodies.","volume":"33","author":"Heyman","year":"2023","journal-title":"Clin Auton Res"},{"key":"R20-20261002","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/jnen\/nlad001","article-title":"Sudden cardiac death in synucleinopathies.","volume":"82","author":"Javanshiri","year":"2023","journal-title":"J Neuropathol Exp Neurol"},{"key":"R21-20261002","doi-asserted-by":"crossref","first-page":"e00916","DOI":"10.1002\/brb3.916","article-title":"Reduced vascular risk factors in Parkinson\u2019s disease dementia and dementia with Lewy bodies compared to Alzheimer\u2019s disease.","volume":"8","author":"Chan","year":"2018","journal-title":"Brain Behav"},{"key":"R22-20261002","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4045\/tidsskr.17.0763","article-title":"Risk factors for frontotemporal dementia.","volume":"138","author":"Rasmussen","year":"2018","journal-title":"Tidsskr Nor Laegeforen"},{"key":"R23-20261002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000495607","article-title":"Smoking and obesity as risk factors in frontotemporal dementia and Alzheimer\u2019s disease: the HUNT study.","volume":"9","author":"Rasmussen Eid","year":"2019","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"R24-20261002","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/acn3.51619","article-title":"Modifiable potential risk factors in familial and sporadic frontotemporal dementia.","volume":"9","author":"Soppela","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"R25-20261002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2047-9158-3-13","article-title":"Cardiovascular risk factors and frontotemporal dementia: a case-control study.","volume":"3","author":"Golimstok","year":"2014","journal-title":"Transl Neurodegener"},{"key":"R26-20261002","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fnins.2018.00847","article-title":"Altered high density lipoprotein composition in behavioral variant frontotemporal dementia.","volume":"12","author":"Kim","year":"2018","journal-title":"Front Neurosci"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:00:37Z","timestamp":1790913637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000730"}},"subtitle":["Exploring Intersections, Risks, and Therapeutic Challenges"],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000730","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]}}}